MILLENNIUM MANAGEMENT LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$251,000
+128.2%
522,725
+439.1%
0.00%
Q4 2018$110,000
-92.7%
96,969
-82.3%
0.00%
-100.0%
Q3 2018$1,512,000
+42.1%
547,814
+83.9%
0.00%
+100.0%
Q2 2018$1,064,000
+167.3%
297,942
+129.7%
0.00%0.0%
Q1 2018$398,000
-97.7%
129,689
-95.2%
0.00%
-95.8%
Q4 2017$17,105,000
+20.5%
2,715,025
+30.8%
0.02%
+9.1%
Q3 2017$14,197,000
+236.9%
2,075,558
+251.2%
0.02%
+175.0%
Q2 2017$4,214,000
+48.5%
590,988
+91.4%
0.01%
+60.0%
Q1 2017$2,838,000
+347.6%
308,807
+96.2%
0.01%
+400.0%
Q4 2016$634,000
+20.1%
157,429
+14.2%
0.00%0.0%
Q3 2016$528,000
-44.8%
137,870
-38.0%
0.00%
-50.0%
Q2 2016$956,000
-74.5%
222,260
-72.5%
0.00%
-77.8%
Q1 2016$3,744,000
-52.4%
808,720
+3.2%
0.01%
-47.1%
Q4 2015$7,861,000
+281.4%
783,777
+183.7%
0.02%
+325.0%
Q3 2015$2,061,000
-88.5%
276,281
-26.9%
0.00%
-88.2%
Q2 2015$17,941,000
+102.7%
378,175
+56.5%
0.03%
+112.5%
Q1 2015$8,853,000
-59.8%
241,623
-56.5%
0.02%
-66.0%
Q4 2014$22,041,000
+120.8%
555,040
+10.9%
0.05%
+88.0%
Q3 2014$9,983,000
+19.8%
500,401
-19.0%
0.02%
+8.7%
Q2 2014$8,330,000
-6.2%
617,522
-24.3%
0.02%
-11.5%
Q1 2014$8,879,000
+143.9%
815,316
+202.8%
0.03%
+136.4%
Q4 2013$3,641,000269,2970.01%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,048,642$3,219,0000.50%
Virtus ETF Advisers LLC 130,920$402,0000.35%
683 Capital Management, LLC 600,000$1,842,0000.16%
Tekla Capital Management LLC 859,322$2,638,0000.10%
DOW CHEMICAL CO /DE/ 65,000$200,0000.07%
Alambic Investment Management, L.P. 115,834$356,0000.05%
A.R.T. Advisors, LLC 262,896$807,0000.03%
Candriam S.C.A. 520,613$1,598,0000.03%
Man Group plc 1,674,341$5,140,0000.02%
Baker Brothers Advisors 935,000$2,870,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders